[{"Assets_0_Q1_USD":9803324000.0,"CIK":"1593034","CommonStockSharesConverted_0_Q1_shares":224864678.0,"CommonStockSharesOutstanding_0_Q1_shares":224864678.0,"Country":"Ireland","EarningsPerShareBasic_1_Q1_USD":-0.08,"EarningsPerShareDiluted_1_Q1_USD":-0.08,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"640358301.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":-90583000.0,"NetIncomeLossConverted_1_Q1_USD":-18573000.0,"OfficialName":"Endo International plc Ordinary Shares","RevenuesConverted_1_Q1_USD":720411000.0,"SP500":"nan","Sector":"Health Care","StockholdersEquity_0_Q1_USD":-494450000.0,"Ticker":"ENDP","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":224594000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":224594000.0,"filed":"20190509","footnote":"nan","form":"10-Q","fp":"Q1","fy":"2019.0","name":"ENDO INTERNATIONAL PLC","period":"20190331","qtrs":"0","uom":"USD"}]